Compare TGTX & U Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TGTX | U |
|---|---|---|
| Founded | 1993 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.6B | 8.0B |
| IPO Year | 2008 | 2020 |
| Metric | TGTX | U |
|---|---|---|
| Price | $49.93 | $43.94 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 21 |
| Target Price | ★ $49.80 | $36.61 |
| AVG Volume (30 Days) | 2.3M | ★ 10.8M |
| Earning Date | 05-04-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1746.67 | 42.86 |
| EPS | ★ 0.17 | N/A |
| Revenue | $2,785,000.00 | ★ $1,849,648,000.00 |
| Revenue This Year | $49.08 | $15.81 |
| Revenue Next Year | $26.69 | $12.93 |
| P/E Ratio | $293.53 | ★ N/A |
| Revenue Growth | N/A | ★ 2.01 |
| 52 Week Low | $26.76 | $16.78 |
| 52 Week High | $59.30 | $52.15 |
| Indicator | TGTX | U |
|---|---|---|
| Relative Strength Index (RSI) | 44.73 | 82.56 |
| Support Level | $45.37 | $43.69 |
| Resistance Level | $58.08 | $48.81 |
| Average True Range (ATR) | 2.12 | 2.15 |
| MACD | -0.51 | 1.27 |
| Stochastic Oscillator | 38.04 | 98.40 |
TG Therapeutics Inc is a fully integrated, commercial-stage biotechnology company focused on acquiring, developing, and commercializing novel treatments for B-cell diseases. In addition to a research pipeline, TG Therapeutics has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI (ublituximab-xiiy) to treat adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, as well as approval from several regulatory agencies outside of the U.S. for BRIUMVI to treat adult patients with RMS who have active disease defined by clinical or imaging features.
Unity Software Inc provides a software platform for creating and operating interactive, real-time 3D content. The platform can be used to create, run, and monetize interactive, real-time 2D and 3D content for mobile phones, tablets, PCs, consoles, and augmented and virtual reality devices. The business is spread across the United States, Greater China, EMEA, APAC, and other Americas, and key revenue is derived from the EMEA region. Its products are used in the gaming industry, retail, automotive, architecture, engineering, and construction.